Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reovirus may be used as a purging modality for breast cancer during ASCT
July 28th, 2005
Reovirus may be used as a purging modality for breast cancer during autologous stem cell transplantation. According to recent research from Canada, "Autologous hematological stem cell transplantation (ASCT) is used for the treatment of many hematological and several solid cancers. ASCT, however, has proven disappointing as a therapeutic strategy for breast cancer." "Our group and others have previously shown that breast cancer micrometastases found in patients' apheresis products (APs) predict shorter progression-free and overall survival. The implications of this finding are 2-fold: (1) contaminating tumor cells (CTCs) in AP reflect a higher...
Source: Women's Health Weekly (2005-07-28)
|
